Allaker Robert P, Douglas C W Ian
Barts and The London School of Medicine & Dentistry, Queen Mary, University of London, Newark Street, London E1 2AT UK.
Int J Antimicrob Agents. 2009 Jan;33(1):8-13. doi: 10.1016/j.ijantimicag.2008.07.014. Epub 2008 Sep 18.
Control of dental plaque-related diseases has traditionally relied on non-specific removal of plaque by mechanical means. As our knowledge of oral disease mechanisms increases, future treatment is likely to be more targeted, for example at small groups of organisms, single species or at key virulence factors they produce. The aim of this review is to consider the current status as regards novel treatment approaches. Maintenance of oral hygiene often includes use of chemical agents; however, increasing problems of resistance to synthetic antimicrobials have encouraged the search for alternative natural products. Plants are the source of more than 25% of prescription and over-the-counter preparations, and the potential of natural agents for oral prophylaxis will therefore be considered. Targeted approaches may be directed at the black-pigmented anaerobes associated with periodontitis. Such pigments provide an opportunity for targeted phototherapy with high-intensity monochromatic light. Studies to date have demonstrated selective killing of Porphyromonas gingivalis and Prevotella intermedia in biofilms. Functional inhibition approaches, including the use of protease inhibitors, are also being explored to control periodontitis. Replacement therapy by which a resident pathogen is replaced with a non-pathogenic bacteriocin-producing variant is currently under development with respect to Streptococcus mutans and dental caries.
传统上,控制牙菌斑相关疾病依赖于通过机械手段非特异性地清除牙菌斑。随着我们对口腔疾病机制的认识不断增加,未来的治疗可能会更具针对性,例如针对一小群微生物、单一物种或它们产生的关键毒力因子。本综述的目的是探讨新型治疗方法的现状。保持口腔卫生通常包括使用化学制剂;然而,合成抗菌药物耐药性问题日益严重,这促使人们寻找替代天然产品。超过25%的处方药和非处方药都来源于植物,因此将考虑天然制剂用于口腔预防的潜力。有针对性的方法可能针对与牙周炎相关的产黑色素厌氧菌。这些色素为高强度单色光的靶向光疗提供了机会。迄今为止的研究表明,生物膜中的牙龈卟啉单胞菌和中间普氏菌可被选择性杀灭。包括使用蛋白酶抑制剂在内的功能抑制方法也在探索中,以控制牙周炎。目前正在针对变形链球菌和龋齿开展用产生细菌素的非致病性变体替代常驻病原体的替代疗法。